Fmoc-D-4-Methoxyphenylalanine: A Key Intermediate in Pharmaceutical R&D
The pharmaceutical research and development (R&D) landscape is continuously seeking innovative molecular building blocks to create novel drug candidates. Among these, protected amino acids hold a special place, particularly those incorporating non-natural configurations like D-amino acids. Fmoc-D-4-Methoxyphenylalanine (CAS 201335-88-8) is a prime example of such a valuable intermediate, widely employed in the synthesis of peptides with enhanced therapeutic properties. This article highlights its importance in pharmaceutical R&D and provides guidance on sourcing this critical chemical.
Fmoc-D-4-Methoxyphenylalanine is a derivative of the amino acid phenylalanine, modified with a methoxy group on the phenyl ring and incorporating the D-configuration. The N-terminal Fmoc group is a standard protecting group in Fmoc-based solid-phase peptide synthesis (SPPS), a cornerstone technique in pharmaceutical research for rapidly assembling peptide chains. The D-configuration of the amino acid is significant; peptides containing D-amino acids often exhibit greater resistance to enzymatic degradation in the body compared to their L-amino acid counterparts. This characteristic can lead to improved pharmacokinetic profiles, such as longer half-lives and better oral bioavailability, making them more attractive as drug candidates. Consequently, Fmoc-D-4-Methoxyphenylalanine serves as a key intermediate for synthesizing peptides with enhanced stability and potentially improved therapeutic outcomes.
As a premier manufacturer and supplier of fine chemicals from China, we are dedicated to supporting the pharmaceutical industry's R&D efforts. Our Fmoc-D-4-Methoxyphenylalanine is supplied with high purity (typically 97-98%) and in a consistent white to off-white powder form. This ensures that researchers can reliably buy this compound for their sensitive synthesis processes, where purity directly correlates with the success and reproducibility of their experiments. Many organizations choose to purchase from our facilities due to our stringent quality control and competitive pricing structure.
The utility of Fmoc-D-4-Methoxyphenylalanine in pharmaceutical R&D spans several critical areas:
- Peptide-Based Drug Development: Essential for creating synthetic peptides that mimic or modulate biological functions, targeting a wide range of diseases.
- Accelerated Synthesis: Its compatibility with SPPS techniques significantly speeds up the process of generating peptide libraries for screening drug targets.
- Structure-Activity Relationship (SAR) Studies: Allows researchers to systematically investigate how the D-configuration and methoxy group affect peptide binding and activity.
- Cost-Effective Sourcing: Accessing this specialty chemical from a Chinese manufacturer provides an economical advantage for R&D budgets, enabling more extensive exploration.
For procurement specialists tasked with sourcing critical R&D materials, identifying a dependable supplier is crucial. We offer transparent pricing, prompt quotation services, and efficient delivery of Fmoc-D-4-Methoxyphenylalanine. When you buy this chemical, you are not just acquiring a product; you are securing a vital link in your research supply chain. Our commitment extends to providing comprehensive documentation, including Certificates of Analysis, to meet regulatory and internal quality assurance requirements.
The demand for D-amino acid derivatives like Fmoc-D-4-Methoxyphenylalanine underscores the sophisticated nature of modern drug discovery. By leveraging our expertise as a chemical supplier, pharmaceutical companies can streamline their procurement processes and focus on innovation. We encourage you to request a quote for your specific needs and experience the benefits of partnering with a leading Chinese manufacturer committed to quality and customer satisfaction.
In summary, Fmoc-D-4-Methoxyphenylalanine is an indispensable intermediate for pharmaceutical R&D, enabling the creation of more stable and effective peptide therapeutics. Partner with us to ensure a high-quality, cost-effective, and reliable supply of this essential chemical building block.
Perspectives & Insights
Core Pioneer 24
“The D-configuration of the amino acid is significant; peptides containing D-amino acids often exhibit greater resistance to enzymatic degradation in the body compared to their L-amino acid counterparts.”
Silicon Explorer X
“This characteristic can lead to improved pharmacokinetic profiles, such as longer half-lives and better oral bioavailability, making them more attractive as drug candidates.”
Quantum Catalyst AI
“Consequently, Fmoc-D-4-Methoxyphenylalanine serves as a key intermediate for synthesizing peptides with enhanced stability and potentially improved therapeutic outcomes.”